Increasing asthma prevalence is driving the Soft Mist Inhalers Market 2026

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Estimated Market Size Of The Soft Mist Inhalers Market During 2026–2030?

The soft mist inhalers market size has demonstrated significant growth in recent years. It is anticipated to increase from $3.06 billion in 2025 to $3.3 billion in 2026, registering a compound annual growth rate (CAGR) of 8.0%. The expansion observed in prior periods can be attributed to factors such as rising asthma prevalence, an increase in copd cases, the limitations of traditional inhalers, the expansion of hospital-based respiratory care, and an aging population.

The market for soft mist inhalers is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $4.48 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. This projected growth during the forecast period is primarily driven by factors such as the rise in home-based respiratory treatments, advancements in inhaler design, escalating pollution levels, a surge in chronic respiratory diseases, and the expansion of outpatient care services. Key trends identified for the forecast period encompass the wider acceptance of soft mist drug delivery technology, an escalating need for inhalers that are easy for patients to use, increasing application in the management of asthma and COPD, the expansion of homecare respiratory devices, and a strong emphasis on enhancing drug deposition efficiency.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24403&type=smp

What Drivers Are Expected To Influence The Soft Mist Inhalers Market During The Forecast Period?

The projected rise in asthma cases is expected to drive the growth of the soft mist inhalers market going forward. Asthma is a chronic respiratory condition defined by inflammation and narrowing of the airways, making breathing difficult. The increased incidence of asthma primarily stems from greater exposure to air pollution, which worsens respiratory conditions and progressively impairs lung function. Soft mist inhalers assist in managing asthma and other chronic obstructive pulmonary diseases by delivering a fine, slow-moving mist of medication directly to the lungs, thereby enhancing drug deposition and providing respiratory relief with minimal coordination effort. For instance, in October 2024, according to the National Asthma Council, an Australia-based non-profit organization, Australia recorded a total of 474 asthma-related deaths in 2023, comprising 325 females and 149 males. This figure is almost identical to the 473 asthma-related deaths reported in 2022, highlighting a consistent trend in asthma mortality over the two years. Therefore, the growing incidence of asthma is fueling expansion in the soft mist inhalers market.

How Are The Various Segments Of The Soft Mist Inhalers Market Categorized?

The soft mist inhalers market covered in this report is segmented –

1) By Product Type: Portable Soft Mist Inhalers, Stationary Soft Mist Inhalers

2) By Application: Asthma, Chronic Obstructive Pulmonary Disease (COPD), Respiratory Diseases, Other Applications

3) By End-User: Hospitals And Clinics, Home Care Settings, Other End-Users

Subsegments:

1) By Portable Soft Mist Inhalers: Handheld Reusable Soft Mist Inhalers, Disposable Single-Use Soft Mist Inhalers, Compact Travel-Friendly Inhalers, Pediatric-Use Portable Soft Mist Inhalers

2) By Stationary Soft Mist Inhalers: Homecare-Use Stationary Inhalers, Hospital-Grade Soft Mist Inhalers, Long-Term Therapy Devices

What Trends Are Affecting The Expansion Of The Soft Mist Inhalers Market?

Leading companies in the soft mist inhalers (SMIs) market are focusing on strategic collaboration strategies to expand their presence and improve product accessibility. These firms aim to leverage complementary strengths and gain a competitive advantage in delivering innovative, patient-centric inhalation therapies by working with research institutions, technology companies, and regional healthcare providers. For example, in 2024, Merxin Ltd., a UK-based company specializing in the design and supply of generic and customized inhaler devices, collaborated with OECHSLERhealth, a Germany-based manufacturer of medical devices, to launch the Soft Mist Inhalers (SMI) Powerhouse. This pioneering initiative is designed to accelerate market entry for drug developers. It encompasses a strategic partnership with OECHSLER Health, combining their manufacturing and assembly expertise with Merxin’s proprietary SMI design. Together, they aspire to establish new industry standards in intellectual property protection, performance, reliability, speed, and cost-effectiveness.

Which Major Firms Influence Developments In The Soft Mist Inhalers Market?

Major companies operating in the soft mist inhalers market are Boehringer Ingelheim Pharma GmbH & Co. KG, AstraZeneca plc, GlaxoSmithKline plc, Novartis International AG, Teva Pharmaceutical Industries Ltd., Viatris Inc., Cipla Limited, Chiesi Farmaceutici S.p.A., Sunovion Pharmaceuticals Inc., Orion Corporation, Lupin Limited, Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., Aurobindo Pharma Limited, Almirall S.A., Sandoz International GmbH, Zydus Lifesciences Limited, Hikma Pharmaceuticals plc, Bial – Portela & Ca. S.A., Menarini Group, Sanofi S.A., Abbott Laboratories, Pfizer Inc., Otsuka Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited

Read the full soft mist inhalers market report here:

https://www.thebusinessresearchcompany.com/report/soft-mist-inhalers-global-market-report

Which Region Is Forecast To Lead The Soft Mist Inhalers Market In Terms Of Market Size?

North America was the largest region in the soft mist inhalers market in 2025. The regions covered in the soft mist inhalers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Soft Mist Inhalers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=24403&type=smp

Browse Through More Reports Similar to the Global Soft Mist Inhalers Market 2026, By The Business Research Company

Smart Inhalers Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-inhalers-global-market-report

Respiratory Inhaler Devices Market Report 2026

https://www.thebusinessresearchcompany.com/report/respiratory-inhaler-devices-global-market-report

Dry Powder Inhaler Market Report 2026

https://www.thebusinessresearchcompany.com/report/dry-powder-inhaler-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795